Foamix Pharmaceuticals LTD (FOMX) Shareholder Opaleye Management Has Lowered Its Stake; Pvh (PVH) Shares Rose While Msd Capital LP Has Trimmed Position

May 25, 2018 - By Linda Rogers

PVH Corp. (NYSE:PVH) Logo

James A. Silverman decreased its stake in Foamix Pharmaceuticals Ltd (FOMX) by 15.94% based on its latest 2017Q4 regulatory filing with the SEC. Opaleye Management Inc sold 182,000 shares as the company’s stock declined 26.36% with the market. The hedge fund run by James A. Silverman held 960,000 shares of the specialty chemicals company at the end of 2017Q4, valued at $5.77 million, down from 1.14M at the end of the previous reported quarter. Opaleye Management Inc who had been investing in Foamix Pharmaceuticals Ltd for a number of months, seems to be less bullish one the $218.72M market cap company. The stock increased 1.89% or $0.1 during the last trading session, reaching $5.4. About 17,220 shares traded. Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) has declined 13.02% since May 25, 2017 and is downtrending. It has underperformed by 24.57% the S&P500.




Glenn Fuhrman decreased its stake in Pvh Corp (PVH) by 62.24% based on its latest 2017Q4 regulatory filing with the SEC. Msd Capital LP sold 151,908 shares as the company’s stock rose 5.58% while stock markets declined. The hedge fund run by Glenn Fuhrman held 92,169 shares of the apparel company at the end of 2017Q4, valued at $12.65 million, down from 244,077 at the end of the previous reported quarter. Msd Capital LP who had been investing in Pvh Corp for a number of months, seems to be less bullish one the $12.21B market cap company. The stock decreased 0.07% or $0.11 during the last trading session, reaching $158.43. About 194,858 shares traded. PVH Corp. (NYSE:PVH) has risen 41.04% since May 25, 2017 and is uptrending. It has outperformed by 29.49% the S&P500.

Since December 13, 2017, it had 0 insider buys, and 16 selling transactions for $65.57 million activity. $323,150 worth of PVH Corp. (NYSE:PVH) shares were sold by FISCHER MARK D. The insider CHIRICO EMANUEL sold $49.09M. DUANE FRANCIS K also sold $3.42 million worth of PVH Corp. (NYSE:PVH) on Tuesday, April 3. $3.10 million worth of PVH Corp. (NYSE:PVH) was sold by NASELLA HENRY on Tuesday, April 3. BAGLIVO MARY sold $158,292 worth of PVH Corp. (NYSE:PVH) on Tuesday, April 10. HOLMES JAMES sold $158,702 worth of stock or 1,008 shares.

More notable recent PVH Corp. (NYSE:PVH) news were published by: Twst.com which released: “PVH Corp.: PVH Corp. to Host Conference Call to Discuss First Quarter 2018 Earnings Results” on May 13, 2018, also Benzinga.com with their article: “7 Biggest Price Target Changes For Friday” published on May 25, 2018, Globenewswire.com published: “Analysis: Positioning to Benefit within Advaxis, elf Beauty, Heron Therapeutics, PVH, Energy Recovery, and AO Smith …” on May 14, 2018. More interesting news about PVH Corp. (NYSE:PVH) were released by: Seekingalpha.com and their article: “Investors take note of margin gains at Ralph Lauren” published on May 23, 2018 as well as Investorplace.com‘s news article titled: “4 Great Stocks to Indulge in a Growing Luxury Goods Market” with publication date: May 18, 2018.

Among 22 analysts covering PVH Corp (NYSE:PVH), 16 have Buy rating, 0 Sell and 6 Hold. Therefore 73% are positive. PVH Corp had 93 analyst reports since August 19, 2015 according to SRatingsIntel. The stock of PVH Corp. (NYSE:PVH) earned “Outperform” rating by Credit Suisse on Friday, August 25. Guggenheim maintained PVH Corp. (NYSE:PVH) rating on Thursday, December 14. Guggenheim has “Buy” rating and $160.0 target. The company was maintained on Friday, August 26 by Buckingham Research. The firm earned “Buy” rating on Wednesday, August 23 by Cowen & Co. Piper Jaffray maintained the shares of PVH in report on Friday, September 29 with “Buy” rating. As per Monday, December 7, the company rating was maintained by Piper Jaffray. Wells Fargo maintained it with “Buy” rating and $18000 target in Thursday, March 29 report. As per Monday, March 28, the company rating was maintained by Deutsche Bank. Barclays Capital maintained PVH Corp. (NYSE:PVH) rating on Thursday, January 25. Barclays Capital has “Overweight” rating and $166 target. As per Thursday, November 30, the company rating was maintained by Telsey Advisory Group.

Investors sentiment decreased to 1.02 in 2017 Q4. Its down 0.02, from 1.04 in 2017Q3. It dropped, as 31 investors sold PVH shares while 165 reduced holdings. 56 funds opened positions while 143 raised stakes. 71.40 million shares or 0.58% more from 70.99 million shares in 2017Q3 were reported. Federated Invsts Pa holds 0.02% or 53,343 shares. Mackenzie holds 17,361 shares or 0.01% of its portfolio. 725 were reported by Tower Limited Liability (Trc). Gateway Investment Advisers Limited Company accumulated 4,031 shares. Shamrock Asset Ltd Liability Com accumulated 303 shares. Walleye Trading Ltd Liability owns 10,922 shares. Blackrock invested in 5.07M shares or 0.03% of the stock. Howe And Rusling Inc reported 0% in PVH Corp. (NYSE:PVH). Gradient Investments Ltd Limited Liability Company reported 20 shares. Amica Pension Fund Board Of Trustees holds 0.05% in PVH Corp. (NYSE:PVH) or 3,002 shares. Oppenheimer Asset Mngmt reported 12,848 shares stake. Moreover, Kentucky Retirement Ins Tru Fund has 0.05% invested in PVH Corp. (NYSE:PVH) for 2,056 shares. 3,874 are held by Pitcairn Communication. Ifrah Fin Inc holds 0.15% or 2,921 shares in its portfolio. Ls Invest Ltd Liability Corporation holds 0.03% of its portfolio in PVH Corp. (NYSE:PVH) for 3,338 shares.

Among 3 analysts covering Foamix Pharmaceuticals (NASDAQ:FOMX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Foamix Pharmaceuticals had 8 analyst reports since August 25, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, December 5 by Guggenheim. On Wednesday, November 29 the stock rating was maintained by H.C. Wainwright with “Buy”. H.C. Wainwright maintained it with “Buy” rating and $12.0 target in Friday, January 5 report. As per Tuesday, May 8, the company rating was maintained by H.C. Wainwright. The stock of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) has “Buy” rating given on Tuesday, April 17 by H.C. Wainwright. The company was downgraded on Tuesday, August 25 by Zacks.

PVH Corp. (NYSE:PVH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.